Patents by Inventor Hannah NGUYEN

Hannah NGUYEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Structured Symmetric Cyclic Peptides as Ligands for Metal Organic Frameworks
    Publication number: 20230374075
    Abstract: Cyclic peptides including the amino acid sequence selected from SEQ ID NO:1-6, multimers thereof, and metal organic frameworks including the cyclic peptides or multimers thereof are provided.
    Type: Application
    Filed: May 17, 2023
    Publication date: November 23, 2023
    Inventors: David Baker, Ryanne Ballard, Asim Bera, Christine Kang, Alex Kang, Xinting Li, Hannah Nguyen, Meerit Said, Patrick Salveson, William H. Sheffler, Shunzhi Wang
  • Synthesis of omecamtiv mecarbil
    Patent number: 11702380
    Abstract: Provided herein are synthetic methods for the preparation of intermediates that are utilized in the synthesis of omecamtiv mecarbil dihydrochloride.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: July 18, 2023
    Assignee: Amgen Inc.
    Inventors: Sebastien Caille, James Murray, Kyle Quasdorf, Hannah Nguyen, Maria Victoria Silva Elipe, Ari Elizabeth Ericson
  • SYNTHESIS OF OMECAMTIV MECARBIL
    Publication number: 20220298099
    Abstract: Provided herein are synthetic methods for the preparation of intermediates that are utilized in the synthesis of omecamtiv mecarbil dihydrochloride.
    Type: Application
    Filed: March 9, 2022
    Publication date: September 22, 2022
    Inventors: Sebastien CAILLE, James MURRAY, Kyle QUASDORF, Hannah NGUYEN, Maria Victoria SILVA ELIPE, Ari Elizabeth ERICSON
  • Inhibitors of EZH2
    Patent number: 9718838
    Abstract: The present invention relates to compounds that inhibit activity of the histone lysine methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, such as hematologic and solid tumors.
    Type: Grant
    Filed: August 22, 2016
    Date of Patent: August 1, 2017
    Assignee: Eli Lilly and Company
    Inventors: Deqi Guo, Anh-Quan Hannah Nguyen, Michael Enrico Richett
  • INHIBITORS OF EZH2
    Publication number: 20170066780
    Abstract: The present invention relates to compounds that inhibit activity of the histone lysine methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat cancer, such as hematologic and solid tumors.
    Type: Application
    Filed: August 22, 2016
    Publication date: March 9, 2017
    Inventors: Esteban DOMINGUEZ, Deqi GUO, Mary Margaret MADER, Anh-Quan Hannah NGUYEN, Miriam DEL PRADO, Michael Enrico RICHETT, Michael John RODRIGUEZ, Yvonne Yee Mai YIP, Kuo-Long YU